Human trials have started in Singapore and the Duke-NUS team is one step closer to producing a viable COVID-19 vaccine. However other researchers in other parts of the world are ahead in the race.

As the world waits with bated breath for a possible end to the pandemic, is a viable COVID-19 vaccine the answer? But creating a viable vaccine is just the first step; producing enough for everyone is a different mountain to climb. As Pfizer-BioNTech, Moderna and other first-generation vaccines become available, what happens to the ones that are a step behind?

Meanwhile, vaccine hesitancy and an ever-growing anti-vaccine movement could threaten to derail our path towards herd immunity through vaccination. Could this lead to prolonging the coronavirus pandemic?

Catch up on Part 1 of The Vaccine Quest: https://youtu.be/Ql1XlSwm4Os

=========
About The Vaccine Quest: The development of vaccines for COVID-19 continues worldwide, including here at Duke-NUS. We follow the team of doctors and researchers and showcase the work that will save the lives of millions.
================
#CNAInsider #TheVaccineQuestCNA #COVID19Vaccine #LunarCov19


For more, SUBSCRIBE to CNA INSIDER!
https://cna.asia/insideryoutubesub

Follow CNA INSIDER on:
Instagram: https://www.instagram.com/cnainsider/
Facebook: https://www.facebook.com/cnainsider/
Website: https://cna.asia/cnainsider